sorafenib side effect management in thyroid cancer
Published 9 years ago • 1.8K plays • Length 6:29Download video MP4
Download video MP3
Similar videos
-
9:47
sorafenib in advanced dtc
-
6:02
hcc: considerations in first-line use of sorafenib
-
1:09
dr. brose discusses the tolerability of sorafenib in thyroid cancer
-
2:47
dr. brose discusses lenvatinib and sorafenib in differentiated thyroid cancer
-
3:18
managing side effects with sorafenib in hcc
-
6:53
sequencing in dtc: lenvatinib and sorafenib
-
4:06
sorafenib
-
1:33
all-trans retinoic acid boosts the efficacy of sorafenib against liver cancer
-
59:14
papillary and follicular thyroid cancer. when and how to treat, or watch and wait. dr. busaidy.
-
6:50
sorafenib: the current standard of care
-
1:59
dr. marcia brose describes sorafenib in rai-resistant differentiated thyroid cancer
-
5:28
assessing response to sorafenib
-
0:11
sorafina (sorafenib) kidney cancer, liver cancer, and thyroid cancer medicine
-
6:51
hcc: use of lenvatinib and sorafenib
-
4:44
sorafenib extends survival in differentiated thyroid cancer
-
1:18
dr. marcia brose on sorafenib in radioactive iodine-resistant thyroid cancer
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
4:40
decision trial: support for sorafenib
-
5:59
frontline lenvatinib vs sorafenib in hcc
-
3:02
using sorafenib in advanced hcc
-
2:16
axitinib showed two-month advantage to sorafenib
-
4:31
phase ii study of everolimus and sorafenib in pts with metastatic differentiated thyroid cancer